Abstract:OBJECTIVE:To clarify the role of RhoC in the growth of hepatocellular carcinoma cells and its molecular mechanism, so as to explore the molecular target of tumor cell growth.METHODS:siRNA-RhoC plasmid was constructed and RhoC gene silencing the cell-line of hepatocellular carcinoma was setup. Cell growth was assessed by MTT assay. AgNORs staining was applied to determine cell proliferation. Plate cell clone test was conducted to examine the capacity of cell clone formation. FACS was adopted to measure the course of cell cycle and semi-quantitative RT-PCR was used to determine the expression of cell cycle proteins. In order to further determine the effect of RhoC expression on cell growth, a RhoC over-expression human hepatocellular cell line was setup by PcDNA3-RhoC plasmid transfection.RESULTS:The inhibition rate of RhoC was 82.3%. From the fourth day of cell culture, the growth of cells in RNAi group was significantly slower than that in parental Bel7402 and negative control groups (0.41 ± 0.10 vs. 0.73 ± 0.11 and 0.71 ± 0.07 respectively, P < 0.05). AgNORs staining showed that average cell stained particles in RNAi group was significantly lower than that in parental Bel7402 and negative control(1.23 ± 0.35 vs. 3.47 ± 0.93 and 3.17 ± 0.78, P < 0.01). Plate clone formation test showed that clone formation efficiency in the RNAi group was notably lower than that in the control group [(20.33 ± 5.42)% vs. (70.58 ± 10.10)% and (69.83 ± 14.77)%, respectively, P < 0.01]. Cell cycle analysis by FACS showed that G(0)/G(1) cell percentage in the RNAi group was significantly higher than that in the control group [(73.14 ± 5.93)% vs. (57.05 ± 5.97)% and (52.99 ± 4.80)%, P < 0.05]. Compared with Bel7402 and negative control groups, the expression of following growth associated genes was significantly decreased: cyclin D1(0.45 ± 0.21 vs. 1.25 ± 0.24 and 1.12 ± 0.15, respectively, P < 0.05)and CDK4 (0.55 ± 0.08 vs. 1.18 ± 0.32 and 1.10 ± 0.29, respectively, P < 0.05); the following genes were notably increased: p16(1.07 ± 0.23 vs. 0.36 ± 0.12 and 0.35 ± 0.13, respectively, P < 0.01)and p21(0.42 ± 0.12 vs. 0.17 ± 0.06 and 0.19 ± 0.08, respectively, P < 0.05). RhoC was highly expressed in PcDNA3-RhoC transfected hepatocellular cell line. From the third day on of the cell culture, cell growth in PcDNA3-RhoC group was remarkably higher than that in the HL7702 and PcDNA3 groups (0.83 ± 0.10 vs. 0.54 ± 0.11 and 0.58 ± 0.55, respectively, P < 0.05).CONCLUSIONS:RhoC is the key molecule in promoting hepatocellular cell growth, and is a promising target for tumor cell growth controlling.

The Inhibitory Effect of P75 Neurotrophin Receptor on Growth of Human Hepatocellular Carcinoma Cells

p75 neurotrophin receptor suppresses the proliferation of human gastric cancer cells.

P75 Neurotrophin Receptor Inhibits Invasion and Metastasis of Gastric Cancer

P75ntr Promotes Survival of Breast Cancer Resistant Cells by Regulating Bcl-2/Bax and MAPK Pathway.

Expression and Prognostic Impact of NTF3 and TrkC in Hepatocellular Carcinoma.

The Inhibitory Effect of HGF on the Proliferation of Human Hepatocellular Carcinoma Cells

Inhibitory Effect of EGFR Antisense Oligodeoxynucleotide on Human Hepatoma Cell Line.

Neuropeptide Y1 receptor inhibits cell growth through inactivating mitogen-activated protein kinase signal pathway in human hepatocellular carcinoma

Human growth hormone and human prolactin function as autocrine/paracrine promoters of progression of hepatocellular carcinoma.

[The Growth Inhibition Effects of TSLC1 Gene on Human Hepatocyte Carcinoma Cell Line HepG2].

Growth Arrest Induced by C75, A Fatty Acid Synthase Inhibitor, Was Partially Modulated by P38 MAPK but Not by P53 in Human Hepatocellular Carcinoma.

Suppress of Cell Proliferation and Survival by Nuclear Factor-kappa B Signaling Pathway Inhibition in Human Hepatocellular Carcinoma SMMC-7721 Cells

Effect of coding transmembrane protein 35 gene on cell proliferation and cell cycle in hepa-toma cells by RNA interference

High-expressed PTPN1 Promotes Tumor Proliferation Signature in Human Hepatocellular Carcinoma

Suppression of Heterogeneous Nuclear Ribonucleoprotein C Inhibit Hepatocellular Carcinoma Proliferation, Migration, and Invasion via Ras/MAPK Signaling Pathway

The p75NTR mediates a bifurcated signal transduction cascade through the NF kappa B and JNK pathways to inhibit cell survival

Neurotrophin3 promotes hepatocellular carcinoma apoptosis through the JNK and P38 MAPK pathways

Inhibitory Effect and Mechanism of Human Tumor Necrosis Factor-α Gene Transfected into Human Hepatoma Transplantation Tumor by LipofectamineTM 2000 in Nude Mice

Downregulation of p57 accelerates the growth and invasion of hepatocellular carcinoma.

Effect of RhoC on Hepatocellular Carcinoma Cell Growth and Related Molecular Mechanisms

Inhibitory Effects of Thioredoxin Reductase Antisense RNA on the Growth of Human Hepatocellular Carcinoma Cells